Improving disease monitoring in myeloma & predicting outcomes from the immune microenvironment

Irene Ghobrial, MD, Dana-Farber Cancer Institute, Boston, MA, discusses strategies to improve the diagnosis and monitoring of multiple myeloma and comments on the potential of using information from the immune microenvironment to predict the long-term outcomes of patients with multiple myeloma. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.